Cargando…
Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella
The development, clinical advancement and licensure of vaccines, and monitoring of vaccine effectiveness could be expedited and simplified by the ability to measure immunological endpoints that can predict a favorable clinical outcome. Antigen-specific and functional antibodies have been described i...
Autores principales: | Ndungo, Esther, Pasetti, Marcela F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670857/ https://www.ncbi.nlm.nih.gov/pubmed/31287754 http://dx.doi.org/10.1080/21645515.2019.1640427 |
Ejemplares similares
-
A Novel Shigella O-Polysaccharide–IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella Serotypes
por: Desalegn, Girmay, et al.
Publicado: (2023) -
Efficient production of immunologically active Shigella invasion plasmid antigens IpaB and IpaH using a cell-free expression system
por: Kapoor, Neeraj, et al.
Publicado: (2021) -
Systems approach to define humoral correlates of immunity to Shigella
por: Bernshtein, Biana, et al.
Publicado: (2022) -
Dynamics of the Gut Microbiome in Shigella-Infected Children during the First Two Years of Life
por: Ndungo, Esther, et al.
Publicado: (2022) -
Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis
por: Ndungo, Esther, et al.
Publicado: (2021)